J&J (JNJ) Seeks Stelara Label Expansion in Juvenile Arthritis
Zacks via Yahoo Finance· 9 months agoJohnson & Johnson’s JNJ pharmaceutical company, Janssen announced that it has submitted a...
From Nurse To Patient: My Journey With Crohn’s Disease
Women's Health via Yahoo News· 3 weeks agoIt takes at least 1 hour to receive the full dose of medicine. After the one-time IV infusion, you...
Will Solid Pharma Unit Performance Drive J&J (JNJ) Q1 Earnings?
Zacks via Yahoo Finance· 1 year agoIn J&J’s Pharma segment, its oncology drugs, Imbruvica and Darzalex as well as psoriasis treatment...
The Zacks Analyst Blog Highlights J&J, Pfizer, BioNTech, and Moderna
Zacks via Yahoo Finance· 3 months agoJ&J launched 20 major products in 2021. Importantly, J&J's single-shot COVID-19 vaccine has become a...
Johnson & Johson Asks FDA for Wider Use of Juvenile Arthritis Drug
TheStreet.com· 9 months agoJohnson & Johnson's Janssen Pharmaceutical said Friday said it asked the FDA for expanded approval of its Stelara drug to treat pediatric patients with juvenile psoriatic ...
J&J (JNJ) to Set the Stage for Pharma Sector Q4 Earnings
Zacks via Yahoo Finance· 5 months agoJohnson & Johnson JNJ will report fourth-quarter and full-year 2021 results on Jan 25, before market...
J&J Simponi Aria Gets FDA Nod for Pediatric Use in Arthritis
Zacks via Yahoo Finance· 2 years agoThe approval of Simponi Aria for pediatric use in active pJIA and active PsA was based on data from...
J&J's (JNJ) Pharma Unit & COVID-19 Vaccine Key to 2021 Growth
Zacks via Yahoo Finance· 1 year agoJohnson & Johnson JNJ began 2021 with the successful development of its single-shot vaccine to...
Will J&J (JNJ) Initiate Pharma Q2 Earnings With a Beat?
Zacks via Yahoo Finance· 11 months agoJ&J’s stock has risen 6.8% this year so far against a decrease of 9.8% for the industry. The Zacks...
AbbVie's (ABBV) Rinvoq Meets Crohn's Disease Study Goals
Zacks via Yahoo Finance· 2 months agoAbbVie's (ABBV) Rinvoq achieves statistical significance with its co-primary endpoints of clinical...